Recursion REC-994 Phase 2 Trial - Dr. Lisa Boyette, Senior Director of Medical Affairs
1:00:44
Introducing Ovid & Graviton's New ROCK2 Inhibitor for CCM
1:02:57
Big Picture Updates on Guidelines, Trials and Biomarkers
59:18
Delaney Fisher Ph.D. Focused Ultrasound Update Webinar
55:15
Cavernous Malformation Mythbusters with Dr. Flemming Dr. Zafar 2024 Patient Conference
29:17
Final Thoughts and Q&A with Dr. Awad - Patient Conference 2024
55:56
Our Roadmap to a CCM Cure
40:15
Research Update Panel - Patient Conference 2024
1:00:47